Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 4Neoplasms 3Breast Neoplasms 3Ovarian Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pituitary Neoplasms 1Neurofibromatoses 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Hydrocephalus 1Headache 1Gallbladder Neoplasms 1Female Breast Carcinoma 1Epilepsy 1Disease Progression 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Brain Edema 1Abdominal Neoplasms 1

Interventions

lorlatinib 1elemene 1capmatinib 1aumolertinib 1aflutinib 1Technetium Tc 99m Aggregated Albumin 1Sunitinib 1Sevoflurane 1Radiotherapy 1Propofol 1Gefitinib 1Fluorouracil 1Craniotomy 1Carboplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma × Sevoflurane × Clear all
NCT04475705 2022-03-16

Propofol vs Sevo for Paediatric Tumor Surgery

Hong Kong Children's Hospital

Phase 4 Recruiting
100 enrolled

Carcinoma, Neoplastic Cells, Circulating, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡